Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alaris Ascendant

Executive Summary

Just two years ago, the merger of Ivac and Imed that created Alaris Medical seemed a last-ditch effort against entrenched industry giants Baxter and Abbott, which were offering customers an IV solutions-pump bundle that threatened Ivac's and Imed's stand-alone technology. Alaris Medical has successfully fought off its much larger competitors, winning important contract positions at many of the leading hospital purchasing groups . But the recent trend toward toward consolidation in medical supplies has company officials worried because Alaris's prospects for growth in its core business are limited.
Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV000812

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel